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Sotos syndrome (SoS) is characterized by overgrowth of prenatal onset, learning disabi­
lity, and characteristic facial appearance; it is usually due to haploinsufficiency of NSD1 
gene at chromosome 5q35. An Italian child was born at 37 weeks of gestation (weight 
2,910 g, 25th–50th centiles; length 50 cm, 75th centile; head circumference 36 cm, 97th 
centile) showing cryptorchidism on the right side, hypertelorism, dolichocephaly, broad 
and prominent forehead, and narrow jaw; the pregnancy was worsened by maternal 
preeclampsia and gestational diabetes, and his mother had a previous history of four 
early miscarriages. The patient showed neonatal jaundice, hypotonia, feeding difficulties, 
frequent vomiting, and gastroesophageal reflux. After the age of 6 months, his weight, 
length, and head circumference were above the 97th centile; psychomotor development 
was delayed. At the age of 9 years, the patient showed also joint laxity and scoliosis. DNA 
sequence analysis of NSD1 gene detected a novel heterozygous mutation (c.521T>A, 
p.Val174Asp) in exon 2. The same mutant allele was also found in the mother and in the 
maternal grandfather of the proband; both the mother and the maternal grandfather of 
the proband showed isolated overgrowth with height above the 97th centile in absence 
of other features of SoS. At present 23 familial cases of SoS have been described 
(two cases with mutation in exon 2 of NSD1 gene); no familial cases of SoS with mutation 
of NSD1 gene and isolated overgrowth have been reported. Probably, point mutations 
of NSD1 gene, and particularly mutations between exon 20 and exon 23, are not likely 
to affect reproductive fitness. Epigenetic mechanisms and intrauterine environment may 
influence phenotypes, therefore genetic tests are not useful to predict the phenotype 
but they are indispensable for the diagnosis of SoS. This is the first Italian familial case 
of SoS with genetic confirmation and the third report in which a missense mutation of 
NSD1 gene is found in three generations of the same family.
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BaCKGRoUND
Sotos syndrome (SoS) was first described by Juan Sotos in 1964; 
it is a rare genetic disorder whose prevalence is estimated to be 
1:14,000 live births (1, 2).
Sotos syndrome is characterized by overgrowth of prenatal 
onset, learning disability, and characteristic facial appearance: 
it has been estimated that at least 90% of patients with SoS 
present these features (2). The head of these patients is typically 
dolichocephalic, and the forehead is broad and prominent; 
palpebral fissures are downslanting, the jaw is narrow with a 
long chin and hair in the frontotemporal region is sparse (2). 
Children with SoS usually present delay of motor development, 
hypotonia, and poor language; they also have difficulties with 
speech and language, and intellectual impairment that remains 
stable throughout life (2). The average birth length approximates 
to the 98th centile, the average birth weight is between the 50th 
and 91st centiles, and the average birth head circumference is 
between the 91st and 98th centiles (2). Even though growth is 
influenced by parental heights, children with SoS usually have a 
height and head circumference at least two SD above the mean 
(2). Height can be normal in adulthood, but macrocephaly is 
usually present at all ages (2). The increased height is usually due 
to an increase in limb length; 75–80% of children also present 
with advanced bone age (2).
Less frequently, patients with SoS present with behavioral 
problems such as autistic spectrum disorders, phobias, and aggres-
sion (2). Cardiac anomalies are identified in 20% of patients (2). 
Most of individuals with SoS have cranial abnormalities found 
on MRI or CT (ventricular dilatation, hypoplasia or agenesis 
of the corpus callosum, mega cisterna magna, cavum septum 
pellucidum, cerebral atrophy, and small cerebellar vermis) (2). 
Joint laxity has been described in at least 20% of patients with 
SoS; affected individuals often present renal anomalies, scoliosis, 
and seizures (2). 15% of pregnancies of children with SoS are 
worsened by maternal preeclampsia, and neonatal complications 
(jaundice, hypotonia, and poor feeding) are very common (2).
Less than 15% of individuals with SoS present with cataract, 
conductive hearing loss, craniosynostosis, vertebral anomalies, 
talipes equinovarus, hemihypertrophy, gastroesophageal reflux, 
hypothyroidism, and cryptorchidism (2). Tumors (sacrococcygeal 
teratoma, neuroblastoma, presacral ganglioma, acute lympho-
blastic leukemia, small cell lung cancer, and soft-tissue sarcoma) 
have been described in about 3% of patients with SoS (2, 3).
In 2002, cloning of the breakpoints of a “de novo” t(5;8)
(q35;q24.1) translocation in a child with SoS led to the discovery 
that SoS is usually due to haploinsufficiency of the NSD1 gene 
that encodes a histone methyltransferase (the nuclear receptor 
SET domain-containing protein 1); the NSD1 gene is located 
at chromosome 5q35, and its haploinsufficiency is caused by 
various mechanisms (truncating mutations, missense mutations, 
splice-site mutations, partial gene deletions, and 5q35 microde-
letions) (1, 2). The histone–lysine N-methyltransferase encoded 
by the NSD1 gene acts as a transcriptional factor capable of both 
negatively and positively influencing transcription, depending 
on the cellular context (2). Intragenic mutations cause 80–85% 
of SoS cases among European and American populations; 
5q35 microdeletions are present in 10–15% of European and 
American cases and in more than 50% of Japanese cases (1). 
No abnormalities of the NSD1 gene have been identified in 
10% of patients (1). Many benign and pathogenic variants of 
NSD1 have been identified, but it is not currently known how 
functional abrogation of NSD1 results in SoS; probably there is a 
link between SoS and MAPK/ERK-signaling pathway, which is 
downregulated in SoS (2, 4). On the other side, the ras interact-
ing protein 1, a downstream Ras effector interfering with the 
MAPK/ERK pathway, is identified upregulated in SoS (4). The 
deregulation of the MAPK/ERK-signaling cascade causes a 
hypertrophic differentiation of NSD1-expressing chondrocytes 
with subsequent statural overgrowth and accelerated skeletal 
maturation in patients with SoS (4).
Furthermore, heterozygous inactivation of the NSD1 gene 
results in loss of repression of growth promoting genes, modestly 
increased plasma levels of IGFBP-2 and IGFBP-6, and reduced 
levels of IGF-I, IGF-II, IGFBP-3, and IGFBP-4 (4). Reduced levels 
of IGF-I and IGF-II are present in short rather than tall stature 
such as observed in SoS, therefore the relationship between NSD1 
and the GH/IGF1 axis is still unclear (4).
In this report, we describe a novel molecular genetic finding in 
the NSD1 gene with related clinical features in an Italian familial 
case of overgrowth syndrome.
Case pReseNtatIoN
The patient was the second child of non-consanguineous healthy 
parents of Italian origin with a history of four early miscarriages. 
He was born at 37 weeks of gestation by spontaneous delivery; the 
pregnancy was affected by maternal preeclampsia and gestational 
diabetes. His birth weight was 2,910 g (between the 25th and 50th 
centiles), his length was 50 cm (75th centile), and his head cir-
cumference was 36 cm (97th centile). Apgar score was 8 at 5 min. 
Physical examination performed at birth revealed cryptorchid-
ism on the right side, hypertelorism, dolichocephalic head with 
broad and prominent forehead, and narrow jaw. Blood glucose 
monitoring in the 24 h following the birth was normal; 48 h after 
birth the newborn showed neonatal jaundice that required pho-
totherapy. Cardiac and abdominal ultrasound examinations were 
normal; cerebral ultrasound study showed a mild periventricular 
hyperechogenicity.
The patient showed hypotonia and severe feeding difficulties 
since he was 3 weeks old; at the age of 1 month, gastroesophageal 
reflux was diagnosed, and frequent vomiting was present since he 
was 6 weeks old. At the age of 7 weeks, the child had an episode of 
Brief Resolved Unexplained Event with cyanosis, absent breath-
ing, marked hypotonia, and unresponsiveness. Later, he showed 
some episodes of apnea with perioral cyanosis. For these reasons, 
the patient underwent cardiorespiratory monitoring and artificial 
feeding with nasogastric tube for 10 days.
The weight gain of the patient was poor until the age of 
6  months because of hypotonia, feeding difficulties, gastroe-
sophageal reflux, and frequent vomiting. Later, he showed exces-
sive growth, and his weight, height, and head circumference were 
above the 97th centile for age and sex. Psychomotor development 
was delayed: the child held up his head at 5 months, rolled over 
taBle 1 | Suggestive findings of Sotos syndrome (SoS) in the proband and 
differential diagnosis with other overgrowth syndromes (1 = Malan syndrome; 
2 = Marshall­Smith syndrome; 3 = Weaver syndrome; 4 = Simpson–Golabi–
Behmel syndrome; 5 = Perlman syndrome; 6 = Bannayan–Riley–Ruvalcaba 
syndrome; 7 = Beckwith–Wiedemann syndrome; 8 = PI3K­related syndromes; 
+ = present; − = absent; NA = not available).
suggestive findings for sos proband other overgrowth 
syndromes
1 2 3 4 5 6 7 8
Broad, prominent forehead + + + + + + − − +
Dolichocephalic head shape + − − − − − − − −
Sparse frontotemporal hair − − − − − − − − −
Downslanting palpebral fissures + + − − + − − − −
Malar flushing − − − − − − − − −
Long narrow face + + − − − − − − −
Long chin − + − − − − − − −
Early developmental delay + + + + + + + + +
Mild/severe intellectual impairment + + + + − − + − +
Height ≥2 SD above the mean + + − + + + + + −
Head circumference ≥2 SD above 
the mean
+ + − + + − + + +
Normal height in adulthood NA + − − − + + + +
Macrocephaly at all ages NA + − + + − + − +
Behavioral problems − + − − + − + − +
Advanced bone age + + + + − + − − −
Cardiac anomalies − − − + + + − − −
Cranial MRI/CT abnormalities − − − + + + − − +
Joint hyperlaxity/pes planus + − − − − − − − −
Maternal preeclampsia + − − − − − − − −
Neonatal complications + + + + + + + + −
Renal anomalies − − − − + + − + −
Scoliosis + + − − + − − − +
Seizures − + − − + − + − +
See Ref. (2, 5–7).
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at 7  months, walked alone at 24  months, spoke a first word at 
30 months and simple phrases at 4 years. At 4 years 6 months, he 
showed advanced bone age corresponding to 6 years.
At the age of 9 years, the patient weighed 51.4 kg (>97th cen-
tile); he was 148.1 cm tall (>97th centile), and his head circumfer-
ence was 60 cm (>97th centile). Physical examination revealed 
dolichocephaly, broad and prominent forehead, downslanting 
palpebral fissures, narrow jaw, hypertelorism, increased limb 
length, joint laxity, and scoliosis; his right testicle was smaller than 
his left one. Intellectual impairment and difficulties with speech 
and language were noted. Sideropenic anemia was demonstrated 
at blood examination.
Clinical findings, after a differential diagnosis with other over-
growth syndromes (Table 1), supported the suspicion of SoS, thus 
molecular genetic analysis was recommended.
laBoRatoRY INVestIGatIoNs aND 
DIaGNostIC tests
Genomic DNA was extracted from peripheral blood lymphocytes 
using EZ1 DNA kit and BioRobot EZ1 (Qiagen, Milan, Italy). All 
coding exons (exons 2–23) and exon–intron boundaries of the NSD1 
gene (Ensembl Gene ID: ENSG00000165671, ENST00000439151) 
were amplified by polymerase chain reaction (PCR) (primers 
sequences and PCR conditions are available on request). PCR 
products were purified with QIAquick PCR purification kit 
(Qiagen, Valencia, CA, USA) and directly sequenced with Big Dye 
Terminator Sequencing Kit version 3.1 (Applied Biosystems, Foster 
City, CA, USA), with the same primers used for the amplification. 
Finally, samples were run on 3130xl Genetic Analyzer (Applied 
Biosystems, Foster City, CA, USA) and analyzed with Sequencing 
Analysis Software (Applied Biosystems, Foster City, CA, USA).
DNA sequence analysis of the NSD1 gene detected a novel 
heterozygous mutation: c.521T>A (p.Val174Asp) in exon 2. The 
same mutant allele was also found in the mother and in the mater-
nal grandfather of the proband. In silico analysis by PolyPhen-2 
predicted it as probably damaging; analysis with Mutation Taster 
predicted the mutation as disease causing. The residue is con-
served among different species.
The mother was the only child of unrelated parents. She was 
45 years old at diagnosis with height of 181.6 cm (>97th centile); 
her weight and head circumference were normal. She had neither 
facial appearance suggestive of SoS nor intellectual impairment; 
she graduated at University and worked as employee. She was 
born as appropriate-for-date, no neonatal complications were 
observed, and her psychomotor development was normal. She 
suffered from Hashimoto thyroiditis and had a previous history 
of four early miscarriages.
The maternal grandfather of the patient was 79  years old at 
diagnosis with height of 195.4 cm (>97th centile); his weight, head 
circumference, and facial appearance were normal. He was born 
as appropriate-for-date, no neonatal complications were observed, 
and his psychomotor development was normal. He graduated at 
senior high school with good results and had worked as employee.
At present, the child undergoes periodic clinical examination 
and investigations because of the increased risk of tumors and 
other complications; orthopedic follow-up for scoliosis is also 
performed. The child participates in a regular class with support, 
and his parents undergo periodic psychological counseling.
Written informed consent for the publication of the present 
case report was obtained from both parents of the proband and 
his maternal grandfather.
DIsCUssIoN
We hypothesized our patient should suffer from SoS because 
of his history of overgrowth, his facial appearance, and the 
presence of many other suggestive findings (Table 1) (2, 5–7). 
However, a differential diagnosis with other overgrowth syn-
dromes was mandatory: a lot of the suggestive findings showed 
by our patient were also characteristic of many other overgrowth 
syndromes but, finally, the history of maternal preeclampsia and 
the presence of dolichocephaly and joint laxity let us suspect SoS 
(Table  1) (2, 5–7). However, the definitive diagnosis required 
necessarily the sequence analysis of NSD1 gene.
In our family, the same mutation in exon 2 of the NSD1 gene 
was present in the proband, in his mother and in his maternal 
grandfather; all the three patients showed overgrowth. In addi-
tion to overgrowth, the proband showed most of the features 
of SoS. At present 23 families with at least two family members 
affected by SoS have been identified as carrier of mutations of 
taBle 2 | Mutations of the NSD1 gene in familial cases of Sotos syndrome.
Case # Nationality patients location Mutation amino acids change Reference
1 Israelite Mother, son Exon 5 2386–2389delGAAA Frameshift (8)
2 Finnish Father, son Exon 2 896delC Frameshift (9)
3 Turkish Mother, daughter, son Exon 23 6532delTGCCCCAGC 2178–2180delCPS (10)
4 German Father, two daughters Exon 18 5737A>G N1913D (11)
5 German Mother, son Exon 2 607G>A V203I (11)
6 German Mother, daughter, son Exon 21 6241T>G L2081V (11)
Exon 23 7576C>T P2526S
7 Finnish Mother, two daughters Exon 5 2333T>G L778X (12)
8 Israelite Mother, daughter Exon 6 3882delT Frameshift (12)
9 Israelite Mother, son Exon 10 4417C>T R1473X (12)
10 Israelite Mother, son Exon 13 4779–4781delTTTinsATTC Frameshift (12)
11 Israelite Mother, daughter Exon 13 4855T>C C1619R (12)
12 Israelite Father, three sons Exon 14 4987C>T R1663C (12)
13 Israelite Mother, daughter Exon 16 5375G>T G1792V (12)
14 German Mother, son Exon 22 6291delG Frameshift (12)
15 German Father, son Exon 22 6370T>C C2124R (12)
16 Turkish Mother, son Exon 23 6614A>G H2205R (12)
17 Dutch Seven members of a three­generation family Exon 23 6605G>A C2202Y (13)
18 Japanese Mother, daughter, two sons Intron 13 IVS13 + 1G>A Skip exon 13 (14)
19 Spanish Father, son Exon 22 A6442delAGCGACCA K2151fsX (15)
20 German Mother, son, daughter Exon 23 6523T>A C2175S (16)
21 Irish Eight members of a three­generation family Exon 20 6115C>T R2039C (17)
22 Korean Mother, daughter Exon 22 6356delA D2119V (18)
23 Italian Three members of a three­generation family Exon 2 521T>A V174A Our case
See Ref. (8–18).
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NSD1 gene associated with overgrowth and other clinical find-
ings of SoS (Table 2) (8–18). Ho¨glund et al. reported a Finnish 
family with two members showing the classical phenotype of SoS: 
both of them had a novel 896delC mutation at exon 2 resulting 
in a frameshift and premature stop codon at nucleotides 955–957 
with truncation of 88% of the predicted polypeptide (9). de Boer 
et  al. reported a family with the eldest son showing advanced 
bone age, developmental delay, and some facial characteristics 
of SoS, and his mother showing overgrowth and some facial 
characteristics of SoS; both the mother and the son were carriers 
of the missense mutation 607G>A at exon 2 of NSD1 gene (11).
Two out of our three patients (the mother and the maternal 
grandfather of the proband) showed the mutation of NSD1 gene 
associated with isolated overgrowth; this finding has never been 
reported previously among familial cases of SoS. Tatton-Brown 
et al. screened more than 300 parents of NSD1-positive patients 
identifying mutations in 11, all of whom showed clinical findings 
of SoS; in other words, they have not seen a case of incomplete 
penetrance for a confirmed pathogenic NSD1 gene mutation 
(12). On the basis of our data, we consider worthwhile to perform 
molecular analyses for SoS in both parents of NSD1-positive 
individuals even when showing isolated overgrowth (2).
According to Table 2, most of familial cases of SoS are caused 
by a point mutation of NSD1 gene; we also suggest a link between 
the location of the mutation in NSD1 gene and the reproductive 
fitness. Nearly half of familial cases of SoS presented with a micro-
deletion or a point mutation between exon 20 and exon 23: on 
the basis of this finding, we hypothesize that mutations between 
exon 20 and exon 23 are not likely to affect reproductive fitness. 
On the other side, more rare mutations in other coding exons, 
such as exon 2, are possibly associated with a defect of fertility 
and early recurrent miscarriages, as described in the mother of 
our proband.
Two Italian siblings with SoS phenotype (psychomotor delay, 
macrocrania, coarse face, and accelerated growth), possibly inher-
ited from their father, had already been described previously but 
genetic tests for SoS were not available at that time, therefore our 
family represents the first Italian familial case of SoS with genetic 
confirmation (19). In addition to this, ours is the third report in 
which a missense mutation of NSD1 gene is found in three genera-
tions of the same family: van Haelst et al. described earlier seven 
members of a three-generation Dutch family with the mutation 
6605G>A/C2202Y in exon 23 of NSD1 gene (13). Furthermore, 
Donnelly et  al. described eight members of a three-generation 
Northern Irish family with SoS caused by the mutation 6115C>T/
R2039C in exon 20 of NSD1 gene (17). Our report confirms that 
variation in phenotype is possible even for patients with the same 
abnormality of NSD1 gene, as previously reported (1, 12, 14, 17, 18). 
Thus, it is possible that stochastic factors, epigenetic mechanisms, 
intrauterine environment, functional polymorphisms in genes 
interacting with NSD1, and intrinsic variability in the regulation 
of downstream targets of NSD1 may be responsible of a different 
expression profile of NSD1 gene; the resulting tissue-specific gene 
expression profile may possibly influence phenotypes of SoS (12). 
According to the previous hypothesis, genetic tests are not useful 
to predict the phenotype.
In conclusion, we identified an Italian family with a novel mis-
sense mutation in exon 2 of NSD1 gene; each member carried 
the same molecular abnormality with variable phenotypes and 
severity, from isolated overgrowth to classical SoS. The present 
family case report will contribute to the understanding of the 
correlation between genotype and phenotype in familial SoS.
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